112 - Coagulation Disorders Flashcards
What are the common hemophilia? 2
Remember they are both __ linked
Factor 8 deficiency (A)
Factor 9 deficiency (B)
X
Elongated PT- factor __ deficiency
Elongated aPTT- __ (/) or __ deficiency
Elongated PT and aPTT- factor //_ or __ deficiency
7 hemophilia (8/9) 11 2,5,10 fibrinogen
Most hemophilia is type _ (_%). In _% of cases there is no __, and within that group __% are from the mother
A 80 30 family history 80
In hemophilia the severity of symptoms is correlated with the degree of the ___
deficiency
Light deficiency (-% functioning factor)- The bleeding is usually secondary to __, over __% will be identified after it or prior to pre-op blood workout
6-30
trauma
25
Medium deficiency (-% functioning factor) or severe deficiency (
1-5
1
hemarthrosis
During childhood, patients with hemophilia may experience __ bleeding or when __.
cerebral bleeding
circumcised
In hemophilia patients, look out for //_ bleedings, as they are life threatening and require immediate treatment.
oropharyngeal
CNC
retroperitoneal
The CBC of an hemophilia patient will reveal elongated __ with normal __ time and __. Diagnosis is possible only after specific examination of factors / function
aPTT
bleed
platelets
8/9
How hemophilia patients are treated? 1. 2. 3. 4.
recombinant factor
treating acute bleeding
DDAVP
antifibrinolytic drugs
Recombinant factor treatment for hemophilia should keep the factors around _% to avoid __ bleeding- especially to the __
1
spontaneous
joints
Recombinant factor treatment for hemophilia A should be given _ times per week, while in B- _ times per week
3
2
If an acute bleeding has occurred in an hemophilia patient treat with __ ASAP and avoid __treatment.
recombinant factors
antiaggregant
DDAVP is a synthetic __ of __ which increases __ and __ but not __, therefor useful only to __ patients. When used repeatedly may cause __
analogue vasopressin factor 8 factor 9 hemophilia type A tachyphylaxis (rapidly diminishing response to successive doses of a drug)
Antifibrinolytic drugs for hemophilia include: 2
EACA
tranexamic acid
Antifibrinolytic drugs for hemophilia are indicated when: 3. There is not indication to use it for __
gum bleeding
GI bleeding
oral surgery
hematuria
Producing __ which __ the factor treatment is a common and significant complication in hemophilia patients. We can identify the problem using __ tests or __ test
antibodies
inhibit
plasma mixing
Bethesda
Treating bleeding in high responders is done with high concentrations of __ and factors ,,_ or recombinant factor _
prothrombin
7,9,10
7
Eradication therapy is the most effective treatment for antibodies. It is done with ITI (__)
immune tolerance induction
Factor 11 is part of the __ pathway and it activates factor __. Patients will bleed when the factor goes under __%
intrinsic
9
10
Treating factor 11 deficiency is done with __ infusion. In acute bleeding we can use __ drugs. If inhibitors develop- use __/__ or recombinant factor __. Avoid giving __ if inhibitors develop!
FFP antifibrinolytic drugs PCC/aPCC 7 FFP
Dysfibrinogenemia is a rare coagulation disorder, where factor __ is deficient and patients tend to be __
7
asymptomatic
Coagulation disorders with factor _ or _ deficiency tend to have __ symptoms
10
13
Rare coagulation disorders tend to present with __ or __ bleeding, rather than __ bleeding
membranous
umbilical cord
joint